HIKAL Stock View

Hikal Ltd

HIKAL Stock View

(NSE)

Trade

₹ 294

-7.80 | -2.60

Market Cap ₹( Cr.)
36,250.42

Proj. P/E (x)
24.30

Proj. P/BV (x)

Proj. ROE (%)
12.40

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
22,763.00

STRONG BUY

Last Updated On.
24-Sep-2023

 

Copy Link

Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Company operates through two segments: pharmaceuticals and crop protection. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. The Company’s products and services include gabapentin; thiabendazole, and diuron contract development and custom manufacturing of intermediates; application programming interface (APIs); and artificial intelligence (AI’s). The Company supplies its products to customers across the globe in the United States, Japan, Europe, Canada, Southeast Asia, Latin American, India and RoW.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data